SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 10th, 2022 • Century Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledJanuary 10th, 2022 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is made as of January 7, 2022 (the “Effective Date”), by and between Bristol-Myers Squibb Company, a Delaware corporation (the “Investor”), and Century Therapeutics, Inc., a Delaware corporation (the “Company”).